Diabetes Care, Vol 18, Issue 11 1446-1451, Copyright © 1995 by American Diabetes Association

ARTICLES

Congenital malformations in pregnancies complicated by NIDDM

D Towner, SL Kjos, B Leung, MM Montoro, A Xiang, JH Mestman and TA Buchanan
Department of Obstetrics, University of Southern California School of Medicine, Los Angeles, USA.

OBJECTIVE: To determine whether the use of oral hypoglycemic agents during early pregnancy is associated with a risk of congenital malformations in infants of mothers with non-insulin-dependent diabetes mellitus (NIDDM) independent of maternal metabolic control. RESEARCH DESIGN AND METHODS: From a prospectively collected data-base of pregnancies complicated by diabetes at a large urban medical center, we identified 332 consecutive infants born to women with NIDDM who did not participate in a preconceptional diabetes care program. Stepwise logistical regression was used to identify maternal characteristics that were independently associated with risks of major and minor congenital malformations in infants. RESULTS: Overall, 56 (16.9%) of the 332 infants were born with congenital anomalies (11.7% major anomalies and 5.1% minor anomalies). Analysis of data from subgroups of women who were treated with diet therapy, exogenous insulin, or sulfonylurea compounds during the first 8 weeks of gestation did not reveal statistically significant differences in major or minor malformation rates among the three groups. Stepwise logistic regression analysis revealed two maternal characteristics that were independently associated with major malformations in infants: maternal HbA1c at initial presentation for care (direct relationship; P = 0.0007) and the maternal age at onset of diabetes (inverse relationship; P = 0.009). The risk of major malformations was unrelated to the mode of antidiabetic therapy during early pregnancy. No relationship was found between maternal glycemia or treatment modality and rates of minor congenital anomalies. CONCLUSIONS: These data indicate that, in the absence of special preconceptional care, NIDDM is associated with a risk for major congenital anomalies that is in the range reported for pregnancies complicated by insulin-dependent diabetes mellitus. Moreover, the risk in individual patients appears to be related to maternal glycemic control rather than to the mode of antidiabetic therapy during early pregnancy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Cundy, G. Gamble, L. Neale, R. Elder, P. McPherson, P. Henley, and J. Rowan Differing Causes of Pregnancy Loss in Type 1 and Type 2 Diabetes Diabetes Care, October 1, 2007; 30(10): 2603 - 2607. [Abstract] [Full Text] [PDF]

				D. S Feig, G. G Briggs, and G. Koren Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift? Ann. Pharmacother., July 1, 2007; 41(7): 1174 - 1180. [Abstract] [Full Text] [PDF]

				P. Damm, E. R. Mathiesen, K. R. Petersen, and S. Kjos Contraception After Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S236 - S241. [Full Text] [PDF]

				M. C M Macintosh, K. M Fleming, J. A Bailey, P. Doyle, J. Modder, D. Acolet, S. Golightly, and A. Miller Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study BMJ, July 22, 2006; 333(7560): 177. [Abstract] [Full Text] [PDF]

				M. R. Loeken Advances in Understanding the Molecular Causes of Diabetes-Induced Birth Defects Reproductive Sciences, January 1, 2006; 13(1): 2 - 10. [Abstract] [PDF]

				G. D. Harris and R. D. White Diabetes Management and Exercise in Pregnant Patients With Diabetes Clin. Diabetes, October 1, 2005; 23(4): 165 - 168. [Abstract] [Full Text] [PDF]

				R. Li, M. Chase, S.-K. Jung, P. J. S. Smith, and M. R. Loeken Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E591 - E599. [Abstract] [Full Text] [PDF]

				C.-H. Su and G. A. Rouse Congenital Malformations: Diabetic Embryopathy versus Trisomy 13 Journal of Diagnostic Medical Sonography, March 1, 2004; 20(2): 124 - 130. [Abstract] [PDF]

				Z. T. Bloomgarden Neuropathy, Womens' Health, and Socioeconomic Aspects of Diabetes Diabetes Care, June 1, 2002; 25(6): 1085 - 1094. [Full Text] [PDF]

				F.P. Dunne, P.A. Brydon, M. Proffitt, T. Smith, H. Gee, and R.L. Holder Fetal and maternal outcomes in Indo-Asian compared to Caucasian women with diabetes in pregnancy QJM, December 1, 2000; 93(12): 813 - 818. [Abstract] [Full Text] [PDF]

				T. Hahn, S. Barth, U. Weiss, W. Mosgoeller, and G. Desoye Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development? FASEB J, September 1, 1998; 12(12): 1221 - 1231. [Abstract] [Full Text]

				S. L. Kjos, R. K. Peters, A. Xiang, D. Thomas, U. Schaefer, and T. A. Buchanan Contraception and the Risk of Type 2 Diabetes Mellitus in Latina Women With Prior Gestational Diabetes Mellitus JAMA, August 12, 1998; 280(6): 533 - 538. [Abstract] [Full Text] [PDF]

				H. Dean NIDDM-Y in First Nation Children in Canada Clinical Pediatrics, February 1, 1998; 37(2): 89 - 96. [Abstract] [PDF]

				R J Jarrett Should we screen for gestational diabetes? "The concept of gestational diabetes was popularised before considerations of evidence based medicine came on the scene" BMJ, September 20, 1997; 315(7110): 736 - 737. [Full Text]

				D. Simmons Persistently poor pregnancy outcomes in women with insulin dependent diabetes BMJ, August 2, 1997; 315(7103): 263 - 264. [Full Text]